Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-18
SponsorMayo Clinic
About this trial
A study to use transcutaneous spinal cord stimulation to characterize sensorimotor deficits in a pediatric population of individuals with spina bifida.
Eligibility criteria
Qualifiers
Congenital diagnosis of myelomeningocele (MMC)
Able to follow verbal commands or instructions.
If female and able to become pregnant, must be willing to use medically-acceptable method of contraception during study participation.
Disqualifiers
Severe cognitive deficits demonstrating inability to communicate needs
Gaping, weeping, or unhealed open wounds at the site of electrode placement
Unhealed fractures on load bearing bones
History of osteoporosis
Trial design
Treatments tested in this trial
- Transcutaneous stimulation
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov